Skip to content
FrontierPicks

Dormant

M · Macy's Inc.

Conviction · LOW Special situation Catalyst · Consumer discretionary rotation

Last analysed ·

Resolved Graded and closed 2026-07-31 at low conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-19 and is not part of the scored record.

Current thesis

Morgan Stanley broke the all-Hold wall on 2026-07-06, resuming at Overweight with a $30 target and a $3 EPS-power call vs ~$2 consensus — the first real upgrade catalyst since the Q1 beat. But price faded the note ($23.99 → $22.64 by 07-12) before recovering to ~$24, still ~8% under the $26.10 high, with nothing scheduled until the ~early-Sept Q2 print. Base-building, not a breakout.

Kill line

A weekly close below $22 forfeits the July base built after the Morgan Stanley upgrade and confirms the sell-side re-rating failed to attract flow; secondary: the ~2026-09-03 Q2 print landing in-guide ($0.29–$0.34) and missing the ~$0.35 Street number.

Pick status

Played out resolved published kill line did not fire How this is scored →

Latest analysis and events for M —

As of 19 September 2026, the latest FrontierPicks analysis for Macy's Inc. (M): 14 July 2026: Alexandre Choueiri named CEO of Bluemercury, effective 2026-08-03. Luxury-beauty execution hire; operationally relevant, not a tradable catalyst.

Kill line: A weekly close below $22 forfeits the July base built after the Morgan Stanley upgrade and confirms the sell-side re-rating failed to attract flow; secondary: the ~2026-09-03 Q2 print landing in-guide ($0.29–$0.34) and missing the ~$0.35 Street number.

Next dated event on file: — catalyst in 11d.

Current Thesis

Macy's turnaround produced higher guidance on 2026-09-10, but its equity re-rating thesis failed the published $22 weekly-close condition on 2026-09-18. The company raised its fiscal 2026 outlook; the market's adjusted Friday close was $21.94. September results

The interpretation is that the narrative is dead as a July-base re-rating setup — the 2026-09-18 close breached the condition retained in the September 5 research. That classification concerns the published price thesis; it does not establish that the operating turnaround has failed. The original narrative linked improving department-store earnings to broader analyst recognition.

Bullish and bearish views on Macy's Inc.

The model's bull view on Macy's Inc. (M), in brief: Comparable sales exceeded guidance. On 2026-09-10, Macy's reported second-quarter comparable-sales growth of 2.7%, above its June 3 outlook of flat to 1% growth. Company results Full-year earnings outlook increased. Management's 2026-09-10 fiscal 2026 adjusted diluted earnings… The bear view: Refunds contributed to reported earnings. Both cases follow in full.

Bull Case

  • Comparable sales exceeded guidance. On 2026-09-10, Macy's reported second-quarter comparable-sales growth of 2.7%, above its June 3 outlook of flat to 1% growth. Company results
  • Full-year earnings outlook increased. Management's 2026-09-10 fiscal 2026 adjusted diluted earnings per share (EPS) range became $2.15–$2.35, replacing $2.00–$2.20. Company results
  • The bullish analyst maintained support. Stock Analysis records Morgan Stanley reiterating its $30 price target on 2026-09-14. That is continued endorsement by an existing supporter, rather than evidence of a newly enlarged analyst constituency. Analyst history

Bear Case

  • Refunds contributed to reported earnings. Second-quarter adjusted diluted EPS of $0.63 included a $0.23 net tariff-refund benefit, Macy's disclosed on 2026-09-10. The headline figure therefore includes a separately identified refund contribution. Company results
  • Analyst disagreement survived the results. Investing.com reported on 2026-09-17 that UBS retained its $10 price target over market-share concerns. UBS's assessment remains a third-party view, not an established outcome. UBS report
  • The published price condition failed. The adjusted daily-bar series records $21.94 on Friday 2026-09-18, below the $22 weekly-close threshold published on September 5. The fundamental guidance increase did not prevent that breach.

Setup & Price Structure

The supplied adjusted market series shows a 2026-09-18 close of $21.94, a three-month price decline of 10.3%, and a price 15.6% below the $25.99 trailing annual high. The 14-day relative strength index (RSI) was 50.9 that day. These measurements establish price deterioration over the stated period; RSI alone does not establish renewed demand.

Moving-average values, trading-volume comparisons, short interest and current insider transactions are missing from the available evidence. The dated analyst observations above describe coverage, not measured investor positioning. They do not support a crowding or squeeze conclusion.

Catalyst Calendar (next 30 days)

  • 2026-10-01 — Quarterly dividend payment. Macy's declared 19.15 cents per share on 2026-08-28, payable October 1. This is a scheduled distribution, not an earnings test. Company disclosure

As checked on 2026-09-19, the available company calendar identifies the September 10 earnings call and September 15 consumer conference, both elapsed. No subsequent earnings date inside the next 30 days was verified. Company calendar

What Would Change Our Mind

Loss of the July reference shelf is already observable: a weekly close below $22 ends the published re-rating thesis, and the 2026-09-18 close of $21.94 satisfies that condition. Lowering the threshold would change the original test after its outcome.

A subsequent weekly close above $22 would contradict the assessment that price remains below the former shelf; another weekly close below $22 would invalidate that recovery interpretation. Neither event would erase the September 18 breach.

Correlation Notes

This remains a single-name legacy-retail turnaround assessment. The supplied 2026-09-10 headlines paired falling Macy's shares with an oil surge, but simultaneous headlines do not measure correlation or isolate the earnings effect. No paired return series is available, so the evidence does not support attributing the September weakness to a consumer-discretionary group move.

Notes

  • 2026-07-14: Alexandre Choueiri named CEO of Bluemercury, effective 2026-08-03. Luxury-beauty execution hire; operationally relevant, not a tradable catalyst.
  • Macy's fiscal year ends in late January, so FY2026 runs to roughly 2027-01-30; aggregator quarter and year labels for this name frequently disagree with the company's own.
  • Analyst-panel size varies sharply by provider (13 analysts at S&P Global, 40 at another aggregator), so consensus target and EPS figures for this name are not comparable across sources.
  • A 13F is a 45-day-lagged snapshot: the 7.37M-share figure describes holdings as of 2026-06-30 and says nothing about September. Next disclosure due ~2026-11-16.
  • A quarterly dividend is typically declared alongside results; the declared per-share rate at the print is the checkable figure rather than a trailing yield estimate.
  • Q2 FY2026 EPS guidance of $0.29-$0.34 sits below the Street, so an in-guide print reads as a headline miss even with the full-year range intact.
  • Alexandre Choueiri became CEO of Bluemercury effective 2026-08-03 (announced 2026-07-14) — a luxury-beauty execution hire, operationally relevant rather than a tradable catalyst.

Related · shared themes

See also · stocks to watch